Nausea and vomiting
Nausea, the feeling that a patient needs to or is about to vomit, is an extremely common and distressing symptom in patients with life limiting illness. It is often multifactorial with significant psychological influence. Treatment is therefore centred around the cause and type of nausea and is likely to require holistic assessment and intervention.
Assessment should first rule out reversible causes such as constipation or hypercalcaemia. Gastric irritation, reflux, cough, and anxiety equally may respond better to non-antiemetic treatments and need exploring.
Non-drug treatments
- Relaxation techniques
- Psychotherapy
- Acupuncture
- Ginger
- Acupressure bands
Drug Treatment
Potential Causes | Symptomatic features | Suggested Treatment |
---|---|---|
Chemical | ||
Medication induced (opioids, chemotherapy) | Persistent and often severe nausea without relief from vomiting. May coincide with introduction of new medication or chemotherapy times |
|
Uraemia/ hypercalcaemia | ||
Carcinomatosis | ||
Mechanical | ||
Bowel obstruction | Intermittent nausea generally relieved by vomiting. Can be large volume vomit with food debris and potentially faeculent. Reduced/absent bowel movements. +/- colicky abdominal pain |
|
Constipation | ||
Drugs (opioids, anticholinergics) | ||
Autonomic failure and gastric stasis | ||
Hepatomegaly | ||
Physiological | ||
Raised intracranial pressure |
|
|
Radiotherapy | ||
Cerebellar disease |
| |
Gastritis/ oesophagitis | Often associated with reflux, regurgitation and relieved by food |
|
Movement/ positional | Related to movement |
|
Anticipatory | ||
Previous experiences/ psychological |
|
|
Anxiety |
| |
Unclear | ||
No single cause identified | Multiple features and risks |
|
* NB Parkinson’s Disease
Due to the risk of extrapyramidal side effects with many antiemetic medications the medication of choice is domperidone while still able to swallow, for all causes of nausea and vomiting. Ondansetron is also safe but has significant propensity for constipation when taken regularly for >48 hours, which may in turn worsen nausea. In the table above * denotes drugs which should be avoided in Parkinson’s disease.
Where nausea and vomiting are not controlled by domperidone in a patient with Parkinson’s disease, and ondansetron is not appropriate, low dose olanzapine may be beneficial. This of course needs to be under supervision and the risk of extrapyramidal side effects discussed.
DRUG | PRN DOSE | CSCI DOSE |
---|---|---|
Cyclizine | 50mg PO/SC TDS | 150mg |
Ondansetron | 4mg PO/SC TDS | 16mg-24mg |
Domperidone | 10mg PO TDS | UNAVAILABLE |
Haloperidol* |
| 2.5mg-5mg |
Levomepromazine* |
| 6.25mg-25mg |
Metoclopramide* | 10mg PO/SCTDS | 30mg-60mg |
Hyoscine butylbromide | 20mg PO/SC QDS | 60mg-120mg |
Hyoscine hydrobromide |
| 400mcg-1200mcg |
Prochlorperazine* |
| Not available SC in UK |
Olanzapine | 2.5mg-5mg PO ON | Not available SC in UK |